Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Efficacy and Safety of Oliceridine Fumarate Injection for Acute Pain After Abdominal Surgery: a Randomized, Double-blind, Positive-drug Parallel-controlled, Multi-center Clinical Study

NCT06530563 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT06530563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06530563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Efficacy and Safety of Oliceridine Fumarate Injection for Acute Pain After Abdominal Surgery: a Randomized, Double-blind, Positive-drug Parallel-controlled, Multi-center Clinical Study
Lead sponsor
Xiangya Hospital of Central South University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 31, 2025
Completion date
May 31, 2026
Enrollment
606 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, opioid analgesic adverse reaction